Answers are grounded in this paper and cite their sources.
A set of lipidated peptides was in situ synthesised on cotton fabrics using Fmoc-based peptide synthesis. The resulting modified surfaces exhibit highly potent antibacterial activities in two Gram-negative bacteria including Escherichia coli (ATCC 8739) and Pseudomonas aeruginosa (ATCC 9027), along with moderate antibacterial activities in a Gram-positive bacterium Staphylococcus aureus (ATCC 6538P). As anticipated from covalently bound antimicrobial moieties, a representative membrane disintegration assay suggested that the modified surfaces inhibited bacteria by disrupting the integrity of bacterial cell membranes. Without non-natural D-peptides used in previous studies, this new class of non-leaching antibacterial surfaces offer potent activities while having more practical and economical productions. Furthermore, biocompatibility studies suggest that a selected set of surfaces show no toxicity, thus rendering them suitable for biomedical applications.
No takes yet. Share an insight, caveat, or question.
Opitakorn et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: